MedRhythms
MedRhythms: A Boston-based digital therapeutics firm using sensors, music, and software for neurologic interventions.
- 30
- Company
- Portland, ME, USUnited States
MedRhythms: A Boston-based digital therapeutics firm using sensors, music, and software for neurologic interventions.
medrhythmstherapy.comCrawled Oct 15, 2026
The company says music can have healing effects on the body and mind, and that singing or playing an instrument activates the entire brain.
A local company is treating patients who suffer from neurological disorders and brain injuries with the healing powers of music, a type of therapy researchers say is gaining traction in the medical world. MedRhythms, founded by 26-year-old Brian Harris — who earned his master’s degree in music ther
Amidst all of the chatter about music as it relates to business models, it can be easy to forget that music is unlike other "inputs" or assets that businesses utilize. This is true for all art forms, of course, but music - for a variety of reasons - dominates the conversations around the c
(Boston, MA) MedRhythms Therapy, a company providing Neurologic Music Therapy (NMT) to help people recover from neurologic injuries and diseases has recently reached a significant clinical milestone. In August of 2018, the MedRhythms Therapy clinical team surpassed 10,000 hours of direct patient car
Careers at Medrhythms therapy
The page identifies neurologic music therapy as NMT.
MedRhythms partners with Edwards Health Care Services to expand distribution of its **DME-approved neurotherapeutic gait therapy devices**. The collaboration aims to accelerate access for patients using MedRhythms’ wearable solutions designed to support mobility recovery. Edwards Health Care, a durable medical equipment (DME) provider, will help scale adoption of the devices through its established distribution network.
Sep 2025hmenews.comNews article
MedRhythms secures a new **CMS reimbursement code** for its **InTandem® Rehabilitation System**, targeting patients with **chronic stroke gait impairment**. The approval expands insurance coverage for the device, which uses rhythmic auditory stimulation and treadmill training to improve mobility. This marks a key milestone for MedRhythms in broadening access to its gait rehabilitation technology for stroke survivors.
Aug 2024PR NewswireNews article
MedRhythms secures FDA listing for **InTandem™ (MR-001)**, a neurorehabilitation system designed to enhance walking and mobility in adults with chronic stroke. The device leverages evidence-based approaches to support functional recovery. MedRhythms develops technologies aimed at improving neurorehabilitation outcomes for patients with movement impairments.
Jul 2023PR NewswireNews article
MedRhythms reports positive topline results from its pivotal trial testing **MR-001**, a digital therapy designed to address gait impairments in chronic stroke patients. The trial evaluates the intervention’s efficacy in improving mobility for individuals with long-term stroke-related movement challenges. MedRhythms develops digital health solutions targeting neurological conditions.
Jan 2023PR NewswireNews article